Tuesday, February 9, 2010, 11:35pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

Vision-Sciences Inc. (VSCI)

 At 15:04 EST: 1.15 USD  Down 0.05 (4.17%)  
MORE ON VSCI
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Vision-Sciences, Inc. (NCM:VSCI) Delayed quote dataEdit
Last Trade: 1.15 USD
Trade Time: 3:04PM EST
Change: Down 0.05 (4.17%)
Prev Close: 1.20
Open: 1.23
Bid: 0.98 x 500
Ask: N/A
1y Target Est: 5.00
Day's Range: 1.13 - 1.23
52wk Range: 0.75 - 2.17
Volume: 8,500
Avg Vol (3m): 16,776.2
Market Cap: 42.38M
P/E (ttm): N/A
EPS (ttm): -0.30
Div & Yield: N/A (N/A%)
Vision-Sciences Inc. (VSCI)
1d  5d  3m  6m  1y  2y  5y  max 
 Add VSCI to Portfolio   Download Data

HEADLINES
• Vision-Sciences, Inc. Schedules Fiscal Q3 2010 Conference Call for February 12, 2010
GlobeNewswire (Tue 2:56pm)
• VISION SCIENCES INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Wed, Dec 2)
• Vision-Sciences, Inc. Regains Compliance With Nasdaq Listing Rules
GlobeNewswire (Wed, Dec 2)
• VISION SCIENCES INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Tue, Nov 24)
• VISION SCIENCES INC /DE/ Financials
EDGAR Online Financials (Wed, Nov 18)
• VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Fri, Nov 13)
• Vision-Sciences, Inc. Announces $6.2 Million in Revenue for the First Half of Fiscal 2010
GlobeNewswire (Thu, Nov 12)
• VISION SCIENCES INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St
EDGAR Online (Thu, Nov 12)
• Vision-Sciences, Inc. Does Not Satisfy Nasdaq's Requirement to Maintain a Majority of Independent Directors
GlobeNewswire (Thu, Nov 12)
• Q2 2010 Vision-Sciences, Inc. Earnings Release - After Market Close
CCBN (Thu, Nov 12)
More Headlines for VSCI...
ANALYST
EPS Est (next year) (Mar-10) : N/A
EPS Est (in 2 years) (Mar-11) : N/A
Avg Rec (current)*: 1.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Vision-Sciences, Inc. engages in the design, development, manufacture, and marketing of endoscopy products. The company operates through two segments, Medical and Industrial.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices